Turpeinen M - Search Results

1

Sangkuhl K, Stingl JC, Turpeinen M, Altman RB, Klein TE. Sangkuhl K, et al. Among authors: turpeinen m. Pharmacogenet Genomics. 2014 Jan;24(1):62-72. doi: 10.1097/FPC.0000000000000003. Pharmacogenet Genomics. 2014. PMID: 24128936 Free PMC article. Review. No abstract available.

2

Effects of selective serotonin reuptake inhibitors on timolol metabolism in human liver microsomes and cryo-preserved hepatocytes.

Volotinen M, Korjamo T, Tolonen A, Turpeinen M, Pelkonen O, Hakkola J, Mäenpää J. Volotinen M, et al. Among authors: turpeinen m. Basic Clin Pharmacol Toxicol. 2010 Apr;106(4):302-9. doi: 10.1111/j.1742-7843.2009.00487.x. Epub 2009 Nov 11. Basic Clin Pharmacol Toxicol. 2010. PMID: 19912165 Free article.

3

An evaluation of the cytochrome P450 inhibition potential of selected pesticides in human hepatic microsomes.

Abass K, Turpeinen M, Pelkonen O. Abass K, et al. Among authors: turpeinen m. J Environ Sci Health B. 2009 Aug;44(6):553-63. doi: 10.1080/03601230902997766. J Environ Sci Health B. 2009. PMID: 20183062

4

Cytochrome P450 2B6: function, genetics, and clinical relevance.

Turpeinen M, Zanger UM. Turpeinen M, et al. Drug Metabol Drug Interact. 2012;27(4):185-97. doi: 10.1515/dmdi-2012-0027. Drug Metabol Drug Interact. 2012. PMID: 23152403 Review.

5

Effect of clopidogrel and ticlopidine on cytochrome P450 2B6 activity as measured by bupropion hydroxylation.

Turpeinen M, Tolonen A, Uusitalo J, Jalonen J, Pelkonen O, Laine K. Turpeinen M, et al. Clin Pharmacol Ther. 2005 Jun;77(6):553-9. doi: 10.1016/j.clpt.2005.02.010. Clin Pharmacol Ther. 2005. PMID: 15961986 Clinical Trial.

6

Multiple P450 substrates in a single run: rapid and comprehensive in vitro interaction assay.

Turpeinen M, Uusitalo J, Jalonen J, Pelkonen O. Turpeinen M, et al. Eur J Pharm Sci. 2005 Jan;24(1):123-32. doi: 10.1016/j.ejps.2004.10.006. Eur J Pharm Sci. 2005. PMID: 15626586

7

The functional role of CYP2B6 in human drug metabolism: substrates and inhibitors in vitro, in vivo and in silico.

Turpeinen M, Raunio H, Pelkonen O. Turpeinen M, et al. Curr Drug Metab. 2006 Oct;7(7):705-14. doi: 10.2174/138920006778520633. Curr Drug Metab. 2006. PMID: 17073575 Review.

8

Functional expression, inhibition and induction of CYP enzymes in HepaRG cells.

Turpeinen M, Tolonen A, Chesne C, Guillouzo A, Uusitalo J, Pelkonen O. Turpeinen M, et al. Toxicol In Vitro. 2009 Jun;23(4):748-53. doi: 10.1016/j.tiv.2009.03.008. Epub 2009 Mar 26. Toxicol In Vitro. 2009. PMID: 19328226

9

Selective inhibition of CYP2B6-catalyzed bupropion hydroxylation in human liver microsomes in vitro.

Turpeinen M, Nieminen R, Juntunen T, Taavitsainen P, Raunio H, Pelkonen O. Turpeinen M, et al. Drug Metab Dispos. 2004 Jun;32(6):626-31. doi: 10.1124/dmd.32.6.626. Drug Metab Dispos. 2004. PMID: 15155554

10

Effect of renal impairment on the pharmacokinetics of bupropion and its metabolites.

Turpeinen M, Koivuviita N, Tolonen A, Reponen P, Lundgren S, Miettunen J, Metsärinne K, Rane A, Pelkonen O, Laine K. Turpeinen M, et al. Br J Clin Pharmacol. 2007 Aug;64(2):165-73. doi: 10.1111/j.1365-2125.2007.02866.x. Epub 2007 Mar 1. Br J Clin Pharmacol. 2007. PMID: 17335546 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters